Bulletin
Investor Alert

NeuroBo Pharmaceuticals Inc.

NAS: NRBO

GO

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders
/marketstate/country/us
NeuroBo Pharmaceuticals Inc.

After Hours

NRBO
/zigman2/quotes/207284462/composite

$

0.67

Change

+0.0018 +0.27%

Volume

Volume 8,127

Mar 23, 2023, 7:51 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/207284462/composite

Previous close

$ 0.67

$ 0.67

Change

-0.0049 -0.73%

Day low

Day high

$0.66

$0.68

Open
Open: 0.67

52 week low

52 week high

$0.55

$63.85

Open

Market cap

$12.80M

Average volume

887,642

P/E ratio

N/A

Rev. per Employee

N/A

EPS

-15.61

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/nrbo

MarketWatch News on NRBO

  1. Gemphire Therapeutics' stock extends slide, plummets 39% premarket after trial halt

    7:24 a.m. Aug. 10, 2018

    - Tomi Kilgore

  2. Gemphire's stock on track to open at record low

    7:24 a.m. Aug. 10, 2018

    - Tomi Kilgore

  4. Gemphire Therapeutics stock tumbles 17% premarket after trial halt

    7:01 a.m. Aug. 10, 2018

    - Tomi Kilgore

  5. Gemphire's stock on track to open at record low

    7:02 a.m. Aug. 10, 2018

    - Tomi Kilgore

  6. Gemphire Therapeutics downgraded to market perform from outperform at Raymond James

    8:11 a.m. Aug. 7, 2018

    - Tomi Kilgore

  7. Gemphire Therapeutics stock price target raised to $26 from $22 at Raymond James

    8:14 a.m. June 29, 2018

    - Tomi Kilgore

  9. Gemphire Therapeutics started at outperform with $22 stock price target

    8:19 a.m. May 16, 2018

    - Tomi Kilgore

Analyst Ratings

/news/nonmarketwatch/company/us/nrbo

Other News on NRBO

  1. 10-Q: NEUROBO PHARMACEUTICALS, INC.

    7:18 p.m. Nov. 14, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  2. AMRS and MACK among mid-day gainers

    2:13 p.m. Nov. 9, 2022

    - Seeking Alpha

  3. TKC, AIU and NRBO are among pre market gainers

    9:33 a.m. Nov. 9, 2022

    - Seeking Alpha

  4. TASK and BVS among mid-day movers

    1:42 p.m. Nov. 8, 2022

    - Seeking Alpha

  5. GTHX, NRBO and HUDI are among pre market gainers

    9:23 a.m. Nov. 8, 2022

    - Seeking Alpha

  6. CPRT and LUNG among mid-day movers

    1:55 p.m. Nov. 4, 2022

    - Seeking Alpha

  10. BLUE, TUSK and TRVI among mid-day movers

    1:54 p.m. Sept. 20, 2022

    - Seeking Alpha

  11. UPS, CPRX and VLTA among pre market losers

    8:25 a.m. Sept. 16, 2022

    - Seeking Alpha

  12. CSCW, ADTX and NVOS among mid-day movers

    12:45 p.m. Sept. 15, 2022

    - Seeking Alpha

  14. KERN, RYTM and SLNH among mid-day movers

    1:02 p.m. Sept. 14, 2022

    - Seeking Alpha

  15. Block, Nucor, Altimmune among premarket losers' pack

    8:24 a.m. Sept. 14, 2022

    - Seeking Alpha

  16. MDGL, OTLK and ENTB among pre market gainers

    8:16 a.m. Sept. 13, 2022

    - Seeking Alpha

  18. 10-Q: NEUROBO PHARMACEUTICALS, INC.

    4:27 p.m. Aug. 12, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  19. 10-Q: NEUROBO PHARMACEUTICALS, INC.

    4:38 p.m. May 13, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  20. 10-K: NEUROBO PHARMACEUTICALS, INC.

    5:20 p.m. March 31, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  21. Loading more headlines...
/news/pressrelease/company/us/nrbo

Press Releases on NRBO

  13. Hot Penny Stocks to Know About Right Now? 3 to Watch

    6:00 a.m. Sept. 13, 2022

    - Penny Stocks

  15. NeuroBo Pharmaceuticals Announces Reverse Stock Split

    9:15 a.m. Sept. 12, 2022

    - PR Newswire - PRF

  17. NeuroBo Pharmaceuticals Reports Full Year 2021 Financial Results

    8:00 a.m. April 1, 2022

    - PR Newswire - PRF

  18. EVIO Inc. (EVIO) Expands Footprint to Los Angeles

    12:18 p.m. June 4, 2018

    - NetworkNewsWire

Rates »

Mortgage Equity Savings Auto
Link to MarketWatch's Slice.